StockData
Innate Pharma SA logo

Innate Pharma SA (IPHA) stock

IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$1.33−0.07 (-5.34%)

Close on Nov 17, 2026Market cap $124.65MP/E –Yield –

Innate Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for Innate Pharma

Innate Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Innate Pharma figures

See a number that looks wrong?